<DOC>
	<DOCNO>NCT03060473</DOCNO>
	<brief_summary>Preterm premature rupture membrane ( PPROM ) complicate 4 % pregnancy annually . This pregnancy complication major contributor preterm birth result neonatal morbidity mortality . The current standard care PPROM subject gestational age 24 week 0 day 33 week 6 day , administer ampicillin erythromycin total 7 day . Erythromycin cause GI upset subject tolerate regimen course 7 day . In addition , national shortage erythromycin , publish expert opinion propose use second-generation macrolide ( azithromycin ) instead erythromycin . Azithromycin take daily , cheap erythromycin less GI upset adverse effect . The investigator ' objective compare effectiveness 2 regimen prolong pregnancy PPROM . The investigator ' work hypothesis measurable difference primary outcome group randomize azithromycin regimen versus group randomize erythromycin regimen .</brief_summary>
	<brief_title>Treatment ppROM With Erythromycin vs. Azithromycin Trial</brief_title>
	<detailed_description>In United States , preterm premature rupture membrane ( PPROM ) complicate 4 % pregnancy annually . This pregnancy complication major contributor preterm birth result neonatal morbidity mortality . Without treatment , 70-80 % woman deliver within 1st week follow membrane rupture . Multiple trial prove antibiotic give population prolong latency time PPROM delivery , hence reduce maternal neonatal morbidity . According American College Obstetrics Gynecology , current standard care PPROM subject gestational age 24 week 0 day 33 week 6 day , administer ampicillin 2 gm IV every 6 hour 48 hour follow amoxicillin 250 mg orally every 8 hour 5 day , erythromycin 250 mg IV every 6 hour 48 hour follow 500 mg orally every 8 hour 5 day . In regimen , multiple dos intravenous ( IV ) oral ( PO ) dose erythromycin need achieve desire outcome . Erythromycin cause GI upset subject tolerate regimen course 7 day . In addition , national shortage erythromycin , publish expert opinion propose use second-generation macrolide ( azithromycin ) instead erythromycin . This strategy adopt nationwide include maternal center UTMB since 2014 . Compared erythromycin , advantage azithromycin include : - It take orally ( due long intracellular half-life ) . - The entire regimen much cheap multiple erythromycin ( 23 dos ) . - It less gastrointestinal adverse effect . As result , azithromycin commonly use substitute erythromycin many labor delivery unit around country . Despite common use , exist level 1 evidence azithromycin equivalent erythromycin . Haas colleague publish retrospective comparison two regimen 2014 conclude substitution azithromycin erythromycin recommend antibiotic regimen impact latency measure maternal fetal outcome . This study , however , limited non-randomized retrospective nature . The investigator ' objective compare effectiveness 2 regimen prolong pregnancy PPROM . This trial comparative effectiveness pragmatic randomize trial perform singleton pregnancy diagnosis PPROM 24 week 0 day - 32 week 6 day . It compare two well-accepted standardize treatment care subject population : Erythromycin ( FDA Category B ) versus Azithromycin ( FDA Category B ) . The investigator ' primary outcome proportion woman still pregnant day 7 diagnosis PPROM make . The investigator ' work hypothesis measurable difference primary outcome group randomize azithromycin regimen versus group randomize erythromycin regimen . The investigator ' secondary outcome latency define interval PPROM delivery . Data collect consist demographic , obstetrical history , relevant vital sign laboratory . Examples data collect limited include : age , ethnicity/race , gravida , para , receive tocolytics , receive antenatal steroid , gestational age rupture membrane , reason delivery , mode delivery , gestational age delivery , chorioamnionitis , date &amp; time initiation antibiotic , date &amp; time delivery , placental abruption , hospital length stay , number woman undelivered day 7 admission , NICU admission , infant intubation day , neonatal NEC neonatal sepsis . In addition , drug adverse effect profile two assessed post treatment patient survey . The latter assess severity incidence diarrhea symptom nausea vomit severity . The investigator propose total 324 subject need complete study .</detailed_description>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Fetal Membranes , Premature Rupture</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Maternal age ≥ 18 year &lt; 50 year Pregnant woman gestational age 23 6/7 32 6/7 week Singleton pregnancy Preterm premature rupture membrane , determine clinically Cervical dilation visually ≤ 5cm sterile speculum exam . Planned delivery John Sealy Hospital ( JSH ) Intrauterine fetal demise ( fetal heart beat identify document two physician ) Any contraindication expectant management ( e.g . fetal compromise , chorioamnionitis , placental abruption ) Cervical cerclage place Placenta previa know placental anomaly Contraindication antibiotic use ( allergy macrolides ) . Enrolled another trial may affect outcome . Clinical chorioamnionitis active bacterial infection ( e.g . pyelonephritis , pneumonia , abscess ) time randomization : standard antibiotic therapy condition may confound trial intervention . No prenatal care ( le 2 prenatal visit ) Nonresident subject unlikely followedup delivery Any fetal congenital anomaly . Significant liver disease define know cirrhosis elevate transaminase least 3fold upper limit normal Significant renal disease define serum creatinine know &gt; 2.0 mg/dl dialysis . Active congestive heart failure ( EF &lt; 45 % ) pulmonary edema . Immunosuppressed subject : i.e. , take systemic immunosuppressant steroid ( e.g . transplant subject ; include steroid lung maturity ) , HIV CD4 &lt; 200 , .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PPROM</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Erythromycin</keyword>
</DOC>